Fiveash JB - Search Results

1

Pelvic Radiotherapy versus Radical Prostatectomy with Limited Lymph Node Sampling for High-Grade Prostate Adenocarcinoma.

Baker CB, McDonald AM, Yang ES, Jacob R, Rais-Bahrami S, Nix JW, Fiveash JB. Baker CB, et al. Among authors: fiveash jb. Prostate Cancer. 2016;2016:2674954. doi: 10.1155/2016/2674954. Epub 2016 Mar 9. Prostate Cancer. 2016. PMID: 27051534 Free PMC article.

2

Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry.

McDonald AM, Bishop JM, Jacob R, Dobelbower MC, Kim RY, Yang ES, Smith H, Wu X, Fiveash JB. McDonald AM, et al. Among authors: fiveash jb. Prostate Cancer. 2012;2012:546794. doi: 10.1155/2012/546794. Epub 2012 Jun 28. Prostate Cancer. 2012. PMID: 22966463 Free PMC article.

3

Optimal planning target volume margins for elective pelvic lymphatic radiotherapy in high-risk prostate cancer patients.

Hinton BK, Fiveash JB, Wu X, Dobelbower MC, Kim RY, Jacob R. Hinton BK, et al. Among authors: fiveash jb. ISRN Oncol. 2013;2013:941269. doi: 10.1155/2013/941269. Epub 2013 Mar 7. ISRN Oncol. 2013. PMID: 23533814 Free PMC article.

4

Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancer.

McDonald AM, Jacob R, Dobelbower MC, Kim RY, Fiveash JB. McDonald AM, et al. Among authors: fiveash jb. Acta Oncol. 2013 Aug;52(6):1181-8. doi: 10.3109/0284186X.2012.748987. Epub 2013 Apr 2. Acta Oncol. 2013. PMID: 23544356

5

Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapy.

Prendergast BM, Fiveash JB, Popple RA, Clark GM, Thomas EM, Minnich DJ, Jacob R, Spencer SA, Bonner JA, Dobelbower MC. Prendergast BM, et al. Among authors: fiveash jb. J Appl Clin Med Phys. 2013 May 6;14(3):4126. doi: 10.1120/jacmp.v14i3.4126. J Appl Clin Med Phys. 2013. PMID: 23652246 Free PMC article.

6

PSA response to neoadjuvant androgen deprivation is an independent prognostic marker and may identify patients who benefit from treatment escalation.

McDonald AM, Jacob R, Yang ES, Dobelbower MC, Vanlandingham S, Fiveash JB. McDonald AM, et al. Among authors: fiveash jb. Urol Oncol. 2014 Jul;32(5):687-93. doi: 10.1016/j.urolonc.2013.10.019. Epub 2014 Mar 18. Urol Oncol. 2014. PMID: 24656630

7

Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy.

McDonald AM, Baker CB, Popple RA, Shekar K, Yang ES, Jacob R, Cardan R, Kim RY, Fiveash JB. McDonald AM, et al. Among authors: fiveash jb. Radiat Oncol. 2014 Jun 3;9:129. doi: 10.1186/1748-717X-9-129. Radiat Oncol. 2014. PMID: 24893842 Free PMC article.

8

Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapy.

McDonald AM, Baker CB, Shekar K, Popple RA, Clark GM, Yang ES, Jacob R, Kim RY, Fiveash JB. McDonald AM, et al. Among authors: fiveash jb. Urology. 2014 Dec;84(6):1383-7. doi: 10.1016/j.urology.2014.07.060. Epub 2014 Oct 17. Urology. 2014. PMID: 25440987 Free PMC article.

9

Increased radiation dose heterogeneity within the prostate predisposes to urethral strictures in patients receiving moderately hypofractionated prostate radiation therapy.

McDonald AM, Baker CB, Popple RA, Cardan RA, Fiveash JB. McDonald AM, et al. Among authors: fiveash jb. Pract Radiat Oncol. 2015 Sep-Oct;5(5):338-342. doi: 10.1016/j.prro.2015.02.010. Epub 2015 Apr 6. Pract Radiat Oncol. 2015. PMID: 25858771

10

Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience.

Clark GM, McDonald AM, Nabors LB, Fathalla-Shaykh H, Han X, Willey CD, Markert JM, Guthrie BL, Bredel M, Fiveash JB. Clark GM, et al. Among authors: fiveash jb. Neurooncol Pract. 2014 Dec;1(4):172-177. doi: 10.1093/nop/npu028. Neurooncol Pract. 2014. PMID: 26034629 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters